Next Article in Journal
The Prebiotic Effect of an Organic Acid Mixture on Faecalibacterium prausnitzii Metabolism and Its Anti-Pathogenic Role against Vibrio parahaemolyticus in Shrimp
Next Article in Special Issue
Effects of Biological Age on Athletic Adaptations to Combined Plyometric and Sprint with Change of Direction with Ball Training in Youth Soccer Players
Previous Article in Journal
The Dynamics of miR-449a/c Expression during Uterine Cycles Are Associated with Endometrial Development
Previous Article in Special Issue
Does Caffeine Supplementation Associated with Paralympic Powerlifting Training Interfere with Hemodynamic Indicators?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biology
Volume 12
Issue 1
10.3390/biology12010056
biology-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Effects on Respiratory Pressures, Spirometry Biomarkers, and Sports Performance after Inspiratory Muscle Training in a Physically Active Population by Powerbreath®: A Systematic Review and Meta-Analysis

by
Diego Fernández-Lázaro
1,2,*,
Luis A. Corchete
3,
Juan F. García
4,*,
David Jerves Donoso
5,6,
Eva Lantarón-Caeiro
7,8,
Raúl Cobreros Mielgo
9,
Juan Mielgo-Ayuso
10,
David Gallego-Gallego
1 and
Jesús Seco-Calvo
9,11
1
Department of Cellular Biology, Genetics, Histology and Pharmacology, Faculty of Health Sciences, University of Valladolid, Campus of Soria, 42004 Soria, Spain
2
Neurobiology Research Group, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain
3
Cancer Research Center, Biomedical Research Institute, 37007 Salamanca, Spain
4
Department of Mechanical, Informatics and Aerospatiale Engineering, University of Leon, 24071 Leon, Spain
5
Department of Anatomy and Radiology, Faculty of Health Sciences, University of Valladolid, Campus of Soria, 42004 Soria, Spain
6
Pneumology Department of Soria University Assistance Complex (CAUSO), Santa Bárbara Hospital, Castille and Leon Health (SACyL), 42003 Soria, Spain
7
Faculty of Physiotherapy, University of Vigo, Campus A Xunqueira, 36005 Pontevedra, Spain
8
Clinical Physiotherapy Research Group (FS1), Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Faculty of Physical Therapy, University of Vigo, 36005 Ponteveda, Spain
9
Institute of Biomedicine (IBIOMED), Physiotherapy Department, University of Leon, Campus de Vegazana, 24071 Leon, Spain
10
Department of Health Sciences, Faculty of Health Sciences, University of Burgos, 09001 Burgos, Spain
11
Physiology Department, Faculty of Medicine, Basque Country University, 48900 Leioa, Spain
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
Biology 2023, 12(1), 56; https://doi.org/10.3390/biology12010056
Submission received: 14 November 2022 / Revised: 21 December 2022 / Accepted: 25 December 2022 / Published: 29 December 2022
(This article belongs to the Special Issue New Frontiers of Sport, Exercise and Physical Activity for Health and Human Performance)
Browse Figures
Versions Notes

Abstract

:

Simple Summary

There is currently a growing interest in respiratory muscle training in athletes, so we set out to systematically assess with meta-analyses the effects of IMT with PowerBretah® (PwB), a threshold work device for IMT, on respiratory parameters and athletic performance in healthy physically active adults. Eleven studies were included in the systematic review and nine in the meta-analysis. IMT by PwB significantly increased maximal inspiratory pressure (MIP) and substantial improvements in forced vital capacity (FVC) in the results of the meta-analysis, and sports performance was significantly increased. In conclusion, the IMT with PwB would improve respiratory, MIP, FVC, and sports performance.

Abstract

Sports performance in athletes can be limited by respiratory factors, so it is understandable to propose that inspiratory muscle training (IMT) can improve respiratory function and exercise performance. Power-Breathe® (PwB) is a sectorized respiratory muscle training tool that uses a resistive load to train IMT. There is currently a growing interest in respiratory muscle training, so we set out to systematically assess the effects of IMT with PwB on respiratory parameters and athletic performance in physically active, healthy adults. Based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline, the Cochrane and PEDro scales to assess methodological quality, effect size using the Rosenthal formula, and the Cochrane tool for estimation of risk of bias, studies searchable in Medline, Web of Science, and Cochrane. In addition, for the performance of the meta-analysis, the documentation and quantification of the heterogeneity in each meta-analysis were directed through the Cochran’s Q test and the I2 statistic; in addition, a publication bias analysis was performed using funnel plots. Of the total of 241 studies identified in the search, 11 studies for the systematic review and nine for the meta-analysis met the exclusion and/or inclusion criteria. IMT, with PwB, showed significant improvements in maximal inspiratory pressure (MIP) and substantial improvements in forced vital capacity (FVC) in the meta-analysis results. Also, sports performance was significantly increased by IMT with PwB. In conclusion, the use of PwB is an IMT tool that improves respiratory and sports performance.

1. Introduction

The inspiratory muscles are histologically and functionally human skeletal muscle fibers and, therefore, are capable of being trained, like any muscle of the musculoskeletal system [1]. Inspiratory muscle training (IMT) is a technique used to increase the strength or endurance of the diaphragm and accessory muscles of inspiration [2]. IMT are non-pharmacological interventions that are low cost, easy to apply, safe, and are considered important adjuncts to the treatment of some lung diseases [3]. IMT has demonstrated improvements in functional capacity, health-related quality of life (HRQoL), pulmonary function, and dyspnea in patients with respiratory conditions [4].
Physical performance in athletes may be limited by respiratory factors such as respiratory muscle dysfunction, exercise-induced hypoxemia, or the initiation of the respiratory metabolic reflex mechanism of the respiratory muscles [5]. It is therefore understandable to propose that IMT can improve exercise performance. The adaptations brought about by a correct training program can influence the energy metabolism of the respiratory muscles, increasing their efficiency and leading to a lower oxygen demand with respect to skeletal muscles [2]. Thus, IMT is a work-breathing procedure that has a possible ergogenic effect on physical exercise in untrained [6] and trained [7] individuals.
IMT devices, which perform sectorized training of the respiratory muscles, can be divided into three categories, such as: resistive charge, voluntary isocapnic hyperpnea, and threshold devices. In this sense, Power-Breathe® (PwB) [PowerBreathe International Ltd. Southam, Warwickshire; England UK] (IMT Technologies LTD) is a resistive loading IMT instrument. Thus, the IMT effect is generated by the adaptation of the inspiratory muscles to overcome the resistance generated by the PwB during inspiration [8]. A recent meta-analysis reported significant improvements in maximal oxygen consumption (VO2max) and non-significant improvements in plasma lactate concentration, but imputed a publication bias with respect to these two parameters [3]. In addition, Fernández-Lázaro et al. [3] demonstrated only an increase in respiratory pressures in athletes after IMT with PwB but not in other parameters of pulmonary function.
Thus, and due to the growing interest in the IMT, we set out to critically assess the effects of the IMT with PWB on respiratory pressures, the mechanics of respiratory system biomarkers, and athletic performance in physically active, healthy adults. The research question was defined using the PICO model according to the standard methods proposed by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Guidelines (PRISMA) [9] as follows: Population: physically active healthy adults (without any respiratory condition); Intervention: inspiratory muscle training through the PwB device; Comparison: placebo/control group or pre/post comparison data group; Outcomes: respiratory pressures (maximal inspiratory pressure [MIP]), spirometry biomarkers (forced vital capacity [FVC], maximal voluntary ventilation [MVV], peak inspiratory flow [PIF], peak expiratory flow [PEF]) and sports performance (mean values of repeated-sprint ability [RSAmea], exercise time [ET], multistage fitness test repetitive [MSFT], time trail [TT], sprints performance [RSP], mean values of power in time trial [WTTmean], number of repetitions, maximal power [Max Power]). These parameters were included as outcomes as they are commonly investigated in studies of IMT.

2. Methods

2.1. Search Strategy

We developed a structured search using Medline (PubMed), Web of Science (WOS), and Scopus for articles published from the database’s inception to 31 August 2022, restricted to the English and Spanish languages. The search strategy contained terms related to TT and the different outcome biomarkers as well as a combination of these with the Medical Subject Headings (MeSH) index and Boolean operators:: (“Powerbreath”) AND (“muscle” OR “inspiratory muscle training” OR “inspiratory muscle strength”) AND (“performance” OR “athletic performance”) AND (“exercise” OR “physical activity” OR “aerobic capacity” OR “resistance”) (“pulmonary function” OR respiratory parameters”) AND random* (inspiratory muscle training AND atere* AND random*). Two reviewers (D.F.-L. and J.S.-C.) independently screened titles and abstracts, and full texts were sourced for relevant articles. Inclusion criteria were independently assessed, and disagreements were resolved by a third reviewer (L.C.). Additional records were obtained through reference lists that included relevant articles.

2.2. Selection Criteria

The selection of records was based on the following criteria: (a) physically active, healthy adults with moderate levels of physical activity or sports practice (recreational, amateur, or professional) without any respiratory condition (including individuals with moderate levels of physical activity and excluding animals); (b) studies that assessed the effects of IMT with PwB as the only method of respiratory training; (c) clinical trials, randomized and not randomized trials, and pre-test/post-test design studies (excluding records, editorials, reviews, notes, and any other non-original study); (d) studies that evaluated as outcomes (primary or secondary) any respiratory pressure (MIP), spirometry biomarkers (FVC, MVV, PEF, PIF), and sports performance; (e) studies with clear information on the intervention protocol of IMT with PwB. Records that did not meet the criteria were excluded from this systematic review.

2.3. Quality Assessment

We used the critical review form for quantitative studies developed by updated method guidelines for systematic reviews in the Cochrane Collaboration back review group [10] and the PEDro scale for rating the quality of randomized controlled trials [11].

2.4. Quantitative Assessment

A statistical analysis was performed to obtain the main descriptive statistics of central tendency (mean) and dispersion (standard deviation) of the methodological variables of the treatment and of the subjects recruited in the articles analyzed. We calculated the effect size of the results obtained with respect to the different study variables using Rosenthal’s formula [12].

2.5. Risk of Bias Assessment

The Cochrane risk bias assessment tool [13] was used to evaluate the quality of the literature by two reviewers (D.F.-L., J.S.-C.). It is a specific tool to assess the risk of bias in clinical trials. For this, it includes a description and assessment for each item in the risk of bias, which offers us a final evaluation that determines the quality of the article [13]. The eight major sources of bias (sequence generation; sssignment concealment; personal blinding; evaluator blinding; incomplete tracking; data reporting; publication bias; observer bias) were classified into three grades: “Yes” indicates a low risk of bias, “No” indicates a high risk of bias, and “Unclear” indicates a lack of information or uncertainty about the potential for bias, which were assessed using the Cochrane risk of bias assessment tool.

2.6. Meta-Analysis Data Analysis

To carry out the meta-analysis, the methodology used in the study by Fernández-Lázaro et al. [3] was followed. In this way, the heterogeneity calculation was quantified with Cochrane’s I2 statistic. Without heterogeneity, a fixed effect meta-analysis model was used. However, with heterogeneity, a random effect meta-analysis model was used for evaluating tau squared (τ2) by the DerSimonian-Laird method [14]. Regarding the analysis of publication bias, it was performed using funnel plots, whose asymmetry was quantified through Egger’s regression [15]. The process of performing meta-analysis was used with the metaphor package (version 2.1-0) in R (The R Foundation for Statistical Computing, Vienna, Austria).

2.7. Data Extraction

Two reviewers (D.F.-L. and J.S.-C.) reviewed and synthesized the data from all selected studies into a comprehensive table using standardized data extraction. Disagreements were resolved by a third reviewer (D.G.G.). Information extracted from the selected studies included: the name of the first author, year of publication, the country in which the study was conducted, sample size, age, height, and sport activity (Table 1). Also, interventions, instruments, outcomes, and results (Table 2) were included in the review.

3. Results

3.1. Study Selection

Figure 1 details the process of study selection. The literature search resulted in 240 studies, of which 234 studies were included in the WOS, SCOPUS, and PubMed databases and the remaining six studies were from other sources, such as ResearchGate and reference lists of relevant studies. Thirty-nine duplicates were eliminated, and 195 identified articles were evaluated. Thirty-one manuscripts were included as prospective studies after analysis by title/abstract. After this process, the full text was revised to include a total of 11 records [16,17,18,19,20,21,22,23,24,25,26] in the systematic review.

3.2. Characteristics of Participants

Table 1 shows the main characteristics of the participants included in the selected studies and the athletes’ weekly training. The age of the subjects ranged between 18–32 years, and the height range of the participants was 160–182 cm. Five studies included in the review included soccer players [16,18,21,23,24], three studies rugby and basketball players [21,25,26], one study for each sport: field hockey [21], swimming [20], running [17], and cycling [22].

3.3. Outcome Evaluation

Table 2 summarizes the contents of the studies contained in this systematic review.

3.3.1. Intervention

The intervention carried out in the selected studies is IMT. Ten of included studies indicate as IMT two sets of 30 breaths (2 × 30) daily [16,18,19,20,21,22,23,24,25,26], only Edwards et al. [17] used 1 × 30 breaths daily. Three studies [17,23,24] included other interventions such as a warm-up [23,24], cardiovascular physical activity [17], and interval training [24] plus IMT. Additionally, 2 studies included IMT with soccer [18] and basketball [25] training.

3.3.2. Respiratory Pressures

Ten studies included in the systematic review evaluated MIP [16,17,18,19,20,21,22,23,24,25]. In 9 of the studies, significant increases (p < 0.05) in MIP were obtained in the PwB intervention group with respect to baseline [16,17,18,20,21,22,23,24,25]. In two studies, significant (p < 0.05) improvements were described in the intervention group (IG) with respect to the control group (CG). In addition, substantial improvements in MIP were reported in the IG compared to the CG.

3.3.3. Pulmonary Function

Seven studies included in the review evaluated pulmonary function by FVC [16,17,18,20,21,22,26]. In IG compared to baseline, two studies [16,19] showed non-significant decreases, and Vasconcelos et al. [26] showed significant increases (p < 0.05). Significant increases (p < 0.05) were found in MVV [25], PIF [25] and PEF [26] in the IG compared to baseline.

3.3.4. Sports Performance

All studies [16,17,18,19,20,21,22,23,24,25,26] included in this systematic review evaluated sports performance. Significant [16,18,20,21,23,24,26] (p < 0.05) and non-significant [17,19,22,25] (p > 0.05) increases in performance have been reported in IG from baseline to study completion. In addition, significant improvements in sports performance in IG compared to CG have been described in the study conducted by Edwards et al. [17] in athletes.

3.4. Risk of Bias Assessment

Table 3 shows the analysis of the methodological biases of the studies analyzed in this systematic review by the Cochrane risk bias assessment tool [13]. Two registers presented five biases [17,24], mainly related to allocation concealment, blinding of the personnel, and blinding of the evaluator. Also, three studies presented with four biases [18,19,25] and three studies [20,22,23] presented three biases. Finally, three records showed only two biases [16,21].

3.5. Quality Assessment

3.5.1. PEDro Scale

Three studies were considered “good quality” [16,20,23], seven [18,19,21,22,24,25,26] as “regular quality and one [17] as “poor quality” (Table 4). Items six (therapist blinding) and seven (assessor blinding) are the ones in which studies have shown the most deficiencies.

3.5.2. Cochrane’s Assessment of Quality

Five studies were considered such as “good quality” [16,18,19,23,26], 2 [20,21] as “regular quality and 4 [17,22,24,25] as “poor quality” (Table 5). Items 5 (Was the care provider blinded to the intervention?) and 6 (Was the outcome assessor blinded to the intervention?) are the ones in which studies have shown the most deficiencies.

3.6. Methodological Variables Assessment

The evaluation of the quantitative analysis of the selected studies can be seen in Table 6. Regarding the sample size, experimental deaths in both the experimental and control groups in the different evaluations (pre-treatment and post-treatment) indicate a low number of dropouts during the interventions. As for the experimental mortality data, all the articles provide data after the treatment period, presenting a mean percentage of 2.05% (SD: 4.71) of dropouts due to different causes. However, none of the studies included a follow-up evaluation.

3.7. Effect Size Assessment

Table 7 shows the results of the calculation of the effect size of the selected studies. The effect size offered disparate results depending on the study analyzed. According to this statistical analysis, the treatment had a large effect size (d > 0.8) and thus a greater magnitude of effect. In relation to the improvement of sports performance, Romer et al. [21] (d = 1.81), Tong et al. [24] (d = 0.89), Tong et al. [23] (d = 1.03), and Archiza et al. [16] (d = 1.19) showed a large effect size in their interventions.
For MIP, seven studies showed improvements with a large effect size [16,17,21,22,23,24,25], with an effect size between 1.56 d and 0.95 d. Regarding lung function (FVC), only the study conducted by Romer et al. [21] showed a high effect size (d = 1.29). Vascocelos et al. [26], Salazar-Martínez et al. [22] and Tranchita et al. [25], who obtained significant improvements in FVC, reported results of moderate magnitude (d > 0.5).

3.8. Evaluation of the Results of the Studies Included in the Synthesis and Meta-Analysis (n = 9 Included Studies)

3.8.1. Maximal Inspiratory Pressure (n = 8 Included Studies)

Figure 2 shows the effect of using the PwB on MIP, a statistically significant increase effect is produced (p < 0.05): ROM 1.24; 95% CI, 1.17 to 1.32; Z = 6.94; p = 4 × 10−12 for the studies [16,17,18,21,22,23,24,25] analyzed in the meta-analysis. The publication bias analysis (Figure 3) for the MIP presented a relatively symmetric funnel plot, without any imputed studies, which could indicate that there is no publication bias, although this asymmetry was not statistically significant ’value of Egger’s p = 0.238). Through the “Trim and fill” method, there was no imputation of studies at levels higher than ES and under standard error.

3.8.2. Forced Vital Capacity (n = 6 Included Studies)

Figure 4 shows the effect of using the PwB on FVC, a statistically non-significant increase effect is produced (p > 0.05): ROM 1.02; 95% CI, 1.00 to 1.03; Z = 2.47; p = 0.013 for the studies [16,17,18,21,22,26] analyzed in the meta-analysis. The publication bias analysis (Figure 5) for the MIP presented a relatively symmetric funnel plot, without 2 imputed studies, which could indicate that there is publication bias, and this asymmetry was not statistically significant ’value of Egger’s p = 0.369). Through the “Trim and fill” method, there was imputation of 2 studies at levels higher than ES and under standard error, which could indicate a possible lack of studies at this level.

4. Discussion

The aim of this systematic review was to critically evaluate the effects of IMT with PWB on respiratory pressures, mechanics of the respiratory system, biomarkers, and sports performance in physically active, healthy adults. Eleven studies met the pre-specified inclusion/exclusion criteria. Overall, subjects who performed IMT with PwB showed significant improvements in MIP and substantial improvements in FVC in the meta-analysis results. In addition, this systematic review found significant improvements in sports performance [16,18,20,21,23,24,26] and other spirometry biomarkers such as peak inspiratory flow [25] and peak expiratory flow [26]. The energetic commitment of the respiratory muscles (RMs) with respect to the skeletal muscles that develop active physical activity and the fatigue of the RMs are the two main factors that restrict the respiratory function, causing a decrease in respiratory performance [27]. RMs demand a high percentage of cardiac output (15–20%) in situations of vigorous physical activity, which requires a reduction in the availability of oxygen (O2) for the skeletal muscle involved in the exercise and therefore produces a notable decrease in performance in these athletes [28,29]. Thus, the high O2 needs of RMs during intense exercise conditions generate a competitive demand with respect to active skeletal muscles, which see a significant decrease in the supply of oxygen to their cells, and this causes a decrease in sports performance [30].
During intense and/or prolonged exercise, the appearance of RMs fatigue is possible, following the depletion of its energy substrates [31] and the response of the sympathetic nervous system that activates the respiratory metabolic reflex [3]. The respiratory metabolic reflex involves vasoconstriction that triggers a decrease in blood flow and an increase in the severity of skeletal muscle fatigue, induced by flow and redistributed to preserve respiratory function without compromising RM energy demand [32]. Furthermore, significant decreases in MIP and maximum expiratory pressure (PEM) have been described after long-term and/or intense aerobic physical exercise [33]. However, training the respiratory musculature, particularly IMT, which completes the athlete’s training, attenuates the competition for blood flow, improves tolerance to respiratory fatigue, and increases the efficiency of RMs, all of which have a positive influence on athletic performance [3,34,35].
Our findings indicating benefits in MIP, FVC, and sport performance could be a consequence of adaptations induced by proper IMT program implementation. Especially important could be the improvements in the MIP determined in the meta-analysis, which are also consistent with those reported in other studies [7,36,37,38,39] and in a recent meta-analysis of IMT that found that administering a resistive load of 15% of the MIP achieved significant improvements although they did not reach the pre-established threshold of statistical significance [3]. The substantial improvements in FVC reported in our meta-analysis in athletes are relatively surprising because, in athletes prior to IMT, lung function is close to supraphysiological limits, that is, the values of the main pulmonary ventilation parameters are ≥100% of physiological level [40]. IMT usually induces improvements in FVC in adults with limited lung function [41,42], due to the state of weakness of their respiratory muscles and decreased lung volumes [43,44]. In this sense, IMT in patients with heart failure reduces the magnitude of the respiratory metabolic reflex, which could prevent functional deterioration and MR atrophy and therefore significantly improve lung function [45].
These adaptations to IMT try to modulate homeostatic processes [46] that lead to changes in the oxidative energy metabolism of RMs, gaining in efficiency and causing a lower oxygen demand with respect to skeletal muscles [28,29], tissue remodeling of RMs (hypertrophy of the diaphragm, increase of type II fibers) that increases their strength and functionality [34], and the delay of the respiratory metabolic reflex [3]. Also, PIM´s improvements could also indicate optimization of the neuro-motor control of the respiratory musculature, maintaining the generation of pressure with a lower motor impulse and greater economy of the respiratory musculature [23]. The achievement of these biological adaptations, which involve totally different mechanisms, would be responsible for improvements in sports performance [47,48]. Significant improvements in IG from baseline and compared to CG athletes [17] have been found in the studies included in the systematic review of different sports modalities as soccer [16,18,21,23,24], swimming [20], rugby [21,23,24], basketball [21], and field hockey [21].
In addition to serving as adjuvant therapy in pathological states [41,42,45,49], IMT could be used in populations that perform jobs with high physical demands, such as the military, emergency services, or high mountain rescuers, who usually carry backpacks and heavy loads [50]. In addition, these populations usually use masks or respiratory devices, thus increasing respiratory work, which would induce early muscle fatigue and a reduction in work tolerance [51].
Evidence presented in this systematic review and meta-analysis suggests that IMT by PwB device is safe and provides significant improvements in MIP and substantial improvements in FVC and sports performance. The mechanisms of improvement of respiratory biomarkers by IMT could have a multifactorial etiology, mainly the attenuation of the respiratory metabolic reflex and the modulation of respiratory muscle fatigue. However, these results on IMT with PwB in physically active, healthy adults without chronic diseases need to be confirmed.

Author Contributions

Conceptualization, D.F.-L., J.S.-C. and J.F.G.; methodology, D.F.-L., L.A.C. and D.G.-G.; statistical analysis: L.A.C.; writing—original draft preparation, D.F.-L.; writing—review and editing, D.F.-L., J.S.-C., D.J.D. and J.F.G.; visualization, E.L.-C., R.C.M. and D.G.-G.; supervision, D.F.-L., J.M.-A. and D.J.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors would like to thank the Recognized Research Group “Aging, Health and Development” of the Institute of Biomedicine (IBIOMED), the Physiotherapy Department, and the University of León for their collaboration in the computer support of infrastructures, bibliographic support, and interpretation of the results obtained; and BIOCORP EUROPE S.L (20140. Andoain, Spain) for providing us with the bibliographic support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bottinelli, R.; Reggiani, C. Human skeletal muscle fibres: Molecular and functional diversity. Prog. Biophys. Mol. Biol. 2000, 73, 195–262. [Google Scholar] [CrossRef] [PubMed]
  2. Fernández-Lázaro, D. Ergogenic Strategies for Optimizing Performance and Health in Regular Physical Activity Participants: Evaluation of the Efficacy of Compressive Cryotherapy, Exposure to Intermittent Hypoxia at Rest and Sectorized Training of the Inspiratory Muscles. Ph.D. Thesis, University of León, León, Spain, 2020. Available online: https://dialnet.unirioja.es/servlet/dctes?codigo=286163 (accessed on 5 September 2022).
  3. Fernández-Lázaro, D.; Gallego-Gallego, D.; Corchete, L.A.; Fernández Zoppino, D.; González-Bernal, J.J.; García Gómez, B.; Mielgo-Ayuso, J. Inspiratory muscle training program using the powerbreath®: Does it have ergogenic potential for respiratory and/or athletic performance? A systematic review with meta-analysis. Int. J. Environ. Res. Public Health 2021, 18, 6703. [Google Scholar] [CrossRef] [PubMed]
  4. Hoffman, M.; Augusto, V.M.; Eduardo, D.S.; Silveira, B.M.F.; Lemos, M.D.; Parreira, V.F. Inspiratory muscle training reduces dyspnea during activities of daily living and improves inspiratory muscle function and quality of life in patients with advanced lung disease. Physiother. Theory Pract. 2021, 37, 895–905. [Google Scholar] [CrossRef] [PubMed]
  5. Fernández-Lázaro, D.; Santamaría, G.; Sánchez-Serrano, N.; Lantarón-Caeiro, E.; Seco-Calvo, J. Efficacy of Therapeutic Exercise in Reversing Decreased Strength, Impaired Respiratory Function, Decreased Physical Fitness, and Decreased Quality of Life Caused by the Post-COVID-19 Syndrome. Viruses 2022, 14, 2797. [Google Scholar] [CrossRef]
  6. Gething, A.D.; Williams, M.; Davies, B. Inspiratory resistive loading improves cycling capacity: A placebo controlled trial. Br. J. Sports Med. 2004, 38, 730–736. [Google Scholar] [CrossRef]
  7. Hartz, C.S.; Sindorf, M.A.G.; Lopes, C.R.; Batista, J.; Moreno, M.A. Effect of Inspiratory Muscle Training on Performance of Handball Athletes. J. Hum. Kinet. 2018, 63, 43–51. [Google Scholar] [CrossRef] [Green Version]
  8. Dickinson, J.; Whyte, G.; McConnell, A. Inspiratory muscle training: A simple cost-effective treatment for inspiratory stridor. Br. J. Sports Med. 2007, 41, 694–695. [Google Scholar] [CrossRef]
  9. Arya, S.; Kaji, A.H.; Boermeester, M.A. PRISMA Reporting Guidelines for Meta-analyses and Systematic Reviews. JAMA Surg. 2021, 156, 789–790. [Google Scholar] [CrossRef]
  10. van Tulder, M.; Furlan, A.; Bombardier, C.; Bouter, L. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine 2003, 28, 1290–1299. [Google Scholar] [CrossRef] [Green Version]
  11. Maher, C.G.; Sherrington, C.; Herbert, R.D.; Moseley, A.M.; Elkins, M. Reliability of the PEDro Scale for Rating Quality of Randomized Controlled Trials. Phys. Ther. 2003, 83, 713–721. [Google Scholar] [CrossRef]
  12. Rosenthal, R.; Rubin, D.B. Meta-Analytic Procedures for Combining Studies With Multiple Effect Sizes. Psychol. Bull. 1986, 99, 400–406. [Google Scholar] [CrossRef]
  13. Higgins, J.P.; Altman, D.G.; Gøtzsche, P.C.; Jüni, P.; Moher, D.; Oxman, A.D.; Savovic, J.; Schulz, K.F.; Weeks, L.; Sterne, J.A.; et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011, 343, d5928. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control Clin. Trials 1986, 7, 177–188. [Google Scholar] [CrossRef]
  15. Friedrich, J.O.; Adhikari, N.K.J.; Beyene, J. The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: A simulation study. BMC Med. Res. Methodol. 2008, 8, 32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Archiza, B.; Andaku, D.K.; Caruso, F.C.R.; Bonjorno, J.C., Jr.; Oliveira, C.R.; de Ricci, P.A.; do Amaral, A.C.; Mattiello, S.M.; Libardi, C.A.; Phillips, S.A.; et al. Effects of inspiratory muscle training in professional women football players: A randomized sham-controlled trial. J. Sports Sci. 2018, 36, 771–780. [Google Scholar] [CrossRef]
  17. Edwards, A.M.; Wells, C.; Butterly, R. Concurrent inspiratory muscle and cardiovascular training differentially improves both perceptions of effort and 5000 m running performance compared with cardiovascular training alone. Br. J. Sports Med. 2008, 42, 523–527. [Google Scholar] [CrossRef] [PubMed]
  18. Guy, J.H.; Edwards, A.M.; Deakin, G.B. Inspiratory muscle training improves exercise tolerance in recreational soccer players without concomitant gain in soccer-specific fitness. J. Strength Cond. Res. 2014, 28, 483–491. [Google Scholar] [CrossRef]
  19. Hart, N.; Sylvester, K.; Ward, S.; Cramer, D.; Moxham, J.; Polkey, M.I. Evaluation of an inspiratory muscle trainer in healthy humans. Respir. Med. 2001, 95, 526–531. [Google Scholar] [CrossRef] [Green Version]
  20. Kilding, A.E.; Brown, S.; McConnell, A.K. Inspiratory muscle training improves 100 and 200 m swimming performance. Eur. J. Appl. Physiol. 2010, 108, 505–511. [Google Scholar] [CrossRef]
  21. Romer, L.M.; McConnell, A.K.; Jones, D.A. Effects of inspiratory muscle training upon recovery time during high intensity, repetitive sprint activity. Int. J. Sports Med. 2002, 23, 353–360. [Google Scholar] [CrossRef]
  22. Salazar-Martínez, E.; Gatterer, H.; Burtscher, M.; Orellana, J.N.; Santalla, A. Influence of Inspiratory Muscle Training on Ventilatory Efficiency and Cycling Performance in Normoxia and Hypoxia. Front. Physiol. 2017, 8, 133. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Tong, T.K.; Fu, F.H.; Chung, P.K.; Eston, R.; Lu, K.; Quach, B.; Nie, J.; So, R. The effect of inspiratory muscle training on high-intensity, intermittent running performance to exhaustion. Appl. Physiol. Nutr. Metab. 2008, 33, 671–681. [Google Scholar] [CrossRef] [PubMed]
  24. Tong, T.K.; Fu, F.H.; Eston, R.; Chung, P.K.; Quach, B.; Lu, K. Chronic and acute inspiratory muscle loading augment the effect of a 6-week interval program on tolerance of high-intensity intermittent bouts of running. J. Strength Cond. Res. 2010, 24, 3041–3048. [Google Scholar] [CrossRef] [PubMed]
  25. Tranchita, E.; Minganti, C.; Musumeci, L.; Squeo, M.R.; Parisi, A. Inspiratory muscles training in young basketball players: Preliminary evaluation. Med. Dello Sport 2014, 67, 411–422. [Google Scholar]
  26. Vasconcelos, T.; Hall, A.; Viana, R. The influence of inspiratory muscle training on lung function in female basketball players—A randomized controlled trial. Porto Biomed. J. 2017, 2, 86–89. [Google Scholar] [CrossRef]
  27. Forster, H.V.; Haouzi, P.; Dempsey, J.A. Control of breathing during exercise. Compr. Physiol. 2012, 2, 743–777. [Google Scholar]
  28. Harms, C.A.; Babcock, M.A.; McClaran, S.R.; Pegelow, D.F.; Nickele, G.A.; Nelson, W.B.; Dempsey, J.A. Respiratory muscle work compromises leg blood flow during maximal exercise. J. Appl. Physiol. 1997, 82, 1573–1583. [Google Scholar] [CrossRef] [Green Version]
  29. Harms, C.A.; Wetter, T.J.; McClaran, S.R.; Pegelow, D.F.; Nickele, G.A.; Nelson, W.B.; Hanson, P.; Dempsey, J.A. Effects of respiratory muscle work on cardiac output and its distribution during maximal exercise. J. Appl. Physiol. 1998, 5, 609–618. [Google Scholar] [CrossRef]
  30. Dempsey, J.A.; Romer, L.; Rodman, J.; Miller, J.; Smith, C. Consequences of exercise-induced respiratory muscle work. Respir. Physiol. Neurobiol. 2006, 151, 242–250. [Google Scholar] [CrossRef]
  31. Ianuzzo, C.D.; Hamilton, N.; O’Brien, P.J.; Desrosiers, C.; Chiu, R. Biochemical transformation of canine skeletal muscle for use in cardiac-assist devices. J. Appl. Physiol. 1990, 68, 1481–1485. [Google Scholar] [CrossRef]
  32. Romer, L.M.; Polkey, M.I. Exercise-induced respiratory muscle fatigue: Implications for performance. J. Appl. Physiol. 2008, 104, 879–888. [Google Scholar] [CrossRef] [Green Version]
  33. Martin, B.J.; Stager, J.M. Ventilatory endurance in athletes and non-athletes. Med. Sci. Sport Exerc. 1981, 13, 21–26. [Google Scholar] [CrossRef]
  34. McConnell, A.K.; Lomax, M. The influence of inspiratory muscle work history and specific inspiratory muscle training upon human limb muscle fatigue. J. Physiol. 2006, 77, 445–457. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. González-Montesinos, J.L.; Pardal, C.V.; Santos, J.R.F.; Muñoz, A.A.; Sepúlveda, J.L.C.; de los Monteros, R.G.E. Efectos del entrenamiento de la musculatura respiratoria sobre el rendimiento. Revisión bibliográfica. Rev. Andal. Med. Del. Deport. 2012, 5, 163–170. [Google Scholar] [CrossRef] [Green Version]
  36. Bailey, S.J.; Romer, L.M.; Kelly, J.; Wilkerson, D.P.; DiMenna, F.J.; Jones, A.M. Inspiratory muscle training enhances pulmonary O2 uptake kinetics and high-intensity exercise tolerance in humans. J. Appl. Physiol. 2010, 109, 457–468. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Griffiths, L.A.; McConnell, A.K. The influence of inspiratory and expiratory muscle training upon rowing performance. Eur. J. Appl. Physiol. 2007, 99, 457–466. [Google Scholar] [CrossRef] [PubMed]
  38. Nicks, C.R.; Morgan, D.W.; Fuller, D.K.; Caputo, J.L. The influence of respiratory muscle training upon intermittent exercise performance. Int. J. Sports Med. 2009, 30, 16–21. [Google Scholar] [CrossRef] [PubMed]
  39. Volianitis, S.; McConnell, A.K.; Jones, D.A. Assessment of maximum inspiratory pressure. Respiration 2001, 68, 22–27. [Google Scholar] [CrossRef] [Green Version]
  40. Durmic, T.; Lazovic, B.; Djelic, M.; Lazic, J.S.; Zikic, D.; Zugic, V.; Dekleva, M.; Mazic, S. Sport-specific influences on respiratory patterns in elite athletes. J. Bras. Pneumol 2015, 41, 516–522. [Google Scholar] [CrossRef] [Green Version]
  41. Beaumont, M.; Forget, P.; Couturaud, F.; Reychler, G. Effects of inspiratory muscle training in COPD patients: A systematic review and meta-analysis. Clin. Respir. J. 2018, 12, 2178–2188. [Google Scholar] [CrossRef]
  42. Basso-Vanelli, R.P.; Di Lorenzo, V.A.; Labadessa, I.G.; Regueiro, E.M.; Jamami, M.; Gomes, E.L.; Costa, D. Effects of Inspiratory Muscle Training and Calisthenics-and-Breathing Exercises in COPD With and Without Respiratory Muscle Weakness. Respir. Care 2016, 61, 50–60. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Mackała, K.; Kurzaj, M.; Okrzymowska, P.; Stodółka, J.; Coh, M.; Rożek-Piechura, K. The Effect of Respiratory Muscle Training on the Pulmonary Function, Lung Ventilation, and Endurance Performance of Young Soccer Players. Int. J. Environ Res. Public Health 2020, 17, 234. [Google Scholar] [CrossRef]
  44. Luzak, A.; Karrasch, S.; Thorand, B.; Nowak, D.; Holle, R.; Peters, A.; Schulz, H. Association of physical activity with lung function in lung-healthy German adults: Results from the KORA FF4 study. BMC Pulm. Med. 2017, 17, 215. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Fernández-Rubio, H.; Becerro-De-bengoa-vallejo, R.; Rodríguez-Sanz, D.; Calvo-Lobo, C.; Vicente-Campos, D.; Chicharro, J.L. Unraveling the Role of Respiratory Muscle Metaboloreceptors under Inspiratory Training in Patients with Heart Failure. Int. J. Environ. Res. Public Health 2021, 18, 1697. [Google Scholar] [CrossRef] [PubMed]
  46. Rivera-Brown, A.M.; Frontera, W.R. Principles of Exercise Physiology: Responses to Acute Exercise and Long-term Adaptations to Training. PMR 2012, 4, 797–804. [Google Scholar] [CrossRef] [PubMed]
  47. Fernández-Lázaro, D.; Mielgo-Ayuso, J.; Santamaría, G.; Gutiérrez-Abejón, E.; Domínguez-Ortega, C.; García-Lázaro, S.M.; Seco-Calvo, J. Adequacy of an Altitude Fitness Program (Living and Training) plus Intermittent Exposure to Hypoxia for Improving Hematological Biomarkers and Sports Performance of Elite Athletes: A Single-Blind Randomized Clinical Trial. Int. J. Environ. Res. Public Health 2022, 19, 9095. [Google Scholar] [CrossRef]
  48. Fernández-Lázaro, D.; Mielgo-Ayuso, J.; Adams, D.P.; González-Bernal, J.J.; Fernández Araque, A.; Cano García, A.C.; Fernandez-Lazaro, C.I. Electromyography: A Simple and Accessible Tool to Assess Physical Performance and Health during Hypoxia Training. A Systematic Review. Sustainability 2020, 12, 9137. [Google Scholar] [CrossRef]
  49. Chung, Y.; Huang, T.Y.; Liao, Y.H.; Kuo, Y.C. 12-Week Inspiratory Muscle Training Improves Respiratory Muscle Strength in Adult Patients with Stable Asthma: A Randomized Controlled Trial. Int. J. Environ. Res. Public Health 2021, 18, 3267. [Google Scholar] [CrossRef]
  50. Brown, P.I.; McConnell, A.K. Respiratory-Related Limitations in Physically Demanding Occupations. Aviat. Space Environ. Med. 2012, 83, 424–430. [Google Scholar] [CrossRef]
  51. Taylor, N.A.S.; Peoples, G.E.; Petersen, S.R. Load carriage, human performance, and employment standards. Appl. Physiol. Nutr. Metab. 2016, 41, S131–S147. [Google Scholar] [CrossRef]
Biology 12 00056 g001 550
Figure 1. Flow diagram depicting the identification and selection processes of relevant studies according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Figure 1. Flow diagram depicting the identification and selection processes of relevant studies according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Biology 12 00056 g001
Biology 12 00056 g002 550
Figure 2. Forest Plot meta-analysis results for Maximal Pressure Inspiratory.
Figure 2. Forest Plot meta-analysis results for Maximal Pressure Inspiratory.
Biology 12 00056 g002
Biology 12 00056 g003 550
Figure 3. Funnel Plot meta-analysis results for Maximal Pressure Inspiratory.
Figure 3. Funnel Plot meta-analysis results for Maximal Pressure Inspiratory.
Biology 12 00056 g003
Biology 12 00056 g004 550
Figure 4. Forest Plot meta-analysis results for Force Vital Capacity.
Figure 4. Forest Plot meta-analysis results for Force Vital Capacity.
Biology 12 00056 g004
Biology 12 00056 g005 550
Figure 5. Funnel Plot meta-analysis results for Force Vital Capacity.
Figure 5. Funnel Plot meta-analysis results for Force Vital Capacity.
Biology 12 00056 g005
Table
Table 1. Characteristics of participants in the selected studies.
Table 1. Characteristics of participants in the selected studies.
First Author and Year of Publicationn (IG)n (CG)Age (Years)Height (cm)Sport ActivityWeekly Training Volume of Athletes
Archiza et al., 2017 [16]Npre = 10
Npost = 10		Npre = 8
Npost = 8		IG: 22.0 (3.9)
CG: 20.1 (2.0)		160.0 (0.1)
160.0 (0.0)		Soccer (p)20 h × wk−1; 60% physical and 40% technical and tactical training
Edwards et al., 2008 [17]Npre = 8
Npost = 8		Npre = 8
Npost = 8		NA180.1 (4.5)
181.3 (5.0)		Running (r)NA
Guy et al., 2014 [18]Npre = 24
Npost = 21		Npre = 12
Npost = 10		IG1: 26.6 (8.2)
IG2: 23.9 (6.7)
CG: 21.3 (4.9)		182.0 (0.1)
175.0 (0.1)
175.0 (0.1)		Soccer (r)Twice-weekly sessions for pre-season training
Hart et al., 2001 [19]Npre = 6
Npost = 6		Npre = 6
Npost = 6		32.0 (4.8)NANANA
Kilding et al., 2016 [20]Npre = 8
Npost = 8		Npre = 8
Npost = 8		IG: 19.1 (2.6)
CG: 19.0 (2.1)		176.5 (4.0)
180.5 (6.5)		Swimming (p)NA
Romer et al., 2001 [21]Npre = 12
Npost = 12		Npre = 12
Npost = 12		IG: 21.3 (1.1)
CG: 20.2 (0.7)		174.0 (0.1)
177.0 (0.1)		Soccer, rugby, field hockey, and basketball (p and/or a)NA
Salazar-Martínez et al., 2017 [22] Npre = 8
Npost = 8		Npre = 8
Npost = 8		IG: 23.4 (2.7)
CG: 25.4 (3.2)		180.2 (3.5)
168.8 (5.1)		Cycling (a)NA
Tong et al., 2008 [23]Npre = 20
Npost = 20		Npre = 10
Npost = 10		IG1: 21.3 (0.9)
IG2: 21.5 (2.1)
CG: 22.0 (2.9)		175.0 (5.4)
174.7 (6.8)
175.0 (5.4)		Soccer & rugby (a)NA
Tong et al., 2010 [24]Npre = 9
Npost = 9		Npre = 9
Npost = 9		IG: 21.1 (1.1)
CG: 22.3 (1.0)		172.9 (3.8)
175.6 (4.0)		Soccer & rugby (a)2–3 h × day−1 for 4–5 days × wk−1
Tranchita et al., 2018 [25]Npre = 15
Npost = 15		Npre = 14
Npost = 14		IG: 21.06 (2.5)
CG: 19.0 (2.1)		181.4 (9.9)
181.1 (9.6)		Basketball (a)8 h × wk−1
Vasconcelos et al., 2017 [26]Npre = 12
Npost = 11		Npre = 11
Npost = 10		IG: 22.0 (5.0)
CG: 18.5 (5.8)		NABasketball (p)NA
Abbreviations: n: sample size; IG: intervention group; CG: control group; Npre: sample size at the baseline; Npost: sample size at the end of the study; IG1: intervention group 1; IG2: intervention group 1; NA: data not available; (p): professional level; (a): amateur level; (r): recreational level; h: hour; wk: week.
Table
Table 2. Studies included in the systematic review of the effect of PowerBreath® in physically active, healthy adults.
Table 2. Studies included in the systematic review of the effect of PowerBreath® in physically active, healthy adults.
StudyTInterventionsInstrumentOutcomes (Units)Results
IG: Changes from BaselineIG vs. CG
Archiza et al., 2017 [16]6IMT (2 × 30)
With PwB device		Mouth pressure meter, spirometerRespiratory pressures MIP (cmH2O)
Pulmonary function FVC (L)
Sports performance RSAmean (s)		↑* MIP
↓ FVC
↑* RSAmean		ND
Edwards et al., 2008 [17]4IMT (1 × 30) + Cardiovascular training (CV1: 5 × 1000 m; CV2: 3 × 1600 m; SP: 20 min)
With PwB device		Mouth pressure meter,
portable ergospirometer		Respiratory pressures MIP (cmH2O)
Pulmonary function FVC (L)
Sports performance ET (s) 1000 m		↑* MIP
↔ FVC
↑ ET		↑* MIP
↔ FVC
↑* ET
Guy et al., 2014 [18]6IMT (2 × 30) + pre-season soccer training (2 days per week)
With PwB device		Spirometer, chronometer, heart rate monitor, lactate analyzerRespiratory pressures MIP (cmH2O)
Pulmonary function-FVC (L)
Sports performance-MSFT (m)		↑* MIP
↓FVC
↑* MSFT		ND
Hart et al., 2001 [19]6IMT (2 × 30)
With PwB device		Mouth pressure meter, spirometer, chronometerRespiratory pressures MIP (cmH2O)
Pulmonary function MVV (L/min)
Sports performance ET (s)		↑ MIP
↑ MVV
↑ ET		↑ MIP
↑ MVV
↑ ET
Kilding et al., 2016 [20]6IMT (2 × 30)
With PwB device		Mouth pressure meter, spirometer, lactate analyzerRespiratory pressures MIP (cmH2O)
Pulmonary function FVC (L)
Sports performance TT 200 m (strokes/min)		↑* MIP
↑ FVC
↑* TT		↑* MIP
↑ FVC
↑ TT
Romer et al., 2001 [21]6IMT (2 × 30)
With PwB device		Pneumotachograph spirometer, hand-held mouth pressure meter, lactate analyzer.Respiratory pressures MIP (cmH2O)
Pulmonary function FVC (L)
Sports performance RSP (s)		↑* MIP
↑ FVC
↑* RSP		ND
Salazar-Martínez et al., 2017 [22]6IMT (2 × 30)
With PwB device		Spirometer, cycloergometer,
portable gas analyzer		Respiratory pressures MIP (cmH2O)
Pulmonary function FVC (L)
Sport performance WTTmean (W)		↑* MIP
↑ FVC
↑ WTT		ND
Tong et al., 2008 [23]6Warm-up + IMT (2 × 30)
With PwB device		Bidirectional gas flow meter,
RPE and RPB scales		Respiratory pressures MIP (cmH2O)
Sports performance (number of repetitions)		↑* MIP
↑* number of repetitions		↑ MIP
↑ number of repetitions
Tong et al., 2010 [24]6Warm-up + IMT (2 × 30) + Interval training
With PwB device		Differential pressure transducer, portable ergospirometerRespiratory pressures MIP (cmH2O)
Sports performance (number of repetitions)		↑* MIP
↑* number of repetitions		↑ MIP
↑ number of repetitions
Tranchita et al., 2018 [25]4IMT (2 × 30)
With PwB device		Spirometer,
Astrand-Rhyming Cycle Ergometer Test		Respiratory pressures MIP (cmH2O)
Pulmonary function PIF (L/min)
Pulmonary function MVV (L/min)
Sports performance Max Power (W)		↑* MIP
↑* PIF
↑*MVV
↑ Max Power		ND
Vasconcelos et al., 2017 [26]4IMT (1 × 30)
With PwB device		SpirometerPulmonary function FVC (L)
Pulmonary function PEF (L/s)		↑* FVC
↑*PEF		ND
Abbreviations: T: temporality (weeks); IG: intervention group; CG: control group; IMT: inspiratory muscle training; (n × 30): 30 dynamic inspiratory efforts twice daily; (1 × 30): 30 dynamic inspiratory efforts once a day; PwB: powerbreathe; CV1: cardiovascular test 1; CV2: cardiovascular test 2; SP: self-paced running; RPE: rate of perceived exertion; RPB: rate of perceived breathlessness; MIP: maximal inspiratory pressure; FVC: forced vital capacity; L: litres; cmH2O: centieater of water; RSP: repetitive sprints performance; MVV: maximal voluntary ventilation; min: minutes; ET: exercise time; s: seconds; m: meters; MSFT: multistage fitness test; RSAmean: mean values of repeated-sprint ability WTTmean: mean values of power in time trials; W: watt; PIF: peak inspiratory flow; PEF: peak expiratory flow; ND: not described; ↑ = no significant increase; ↓ = no significant decrease; ↔ = no significant change. ↑* = significant increase; ↓* = significant decrease.
Table
Table 3. Cochrane’s assessment of risk of bias [13].
Table 3. Cochrane’s assessment of risk of bias [13].
ItemsArchiza
et al.,
2017 [16]		Edwards
et al.,
2008 [17]		Guy
et al.,
2014 [18]		Hart
et al.,
2001 [19]		Kilding et al.,
2016 [20]		Romer
et al.,
2001 [21]		Salazar-Martínez
et al.,
2017 [22]		Tong
et al.,
2008 [23]		Tong
et al.,
2010 [24]		Tranchita
et al.,
2018 [25]		Vascocelos
et al.,
2017 [26]
1NONONONONONONONONONOYES
2YESNONONONONONONONONOYES
3NONOYESNOYESYESYESYESNONONO
4YESNONONONOYESNONONONONO
5YESYESYESYESYESYESYESYESYESYESYES
6YESNONOYESYESYESYESYESNOYESYES
7YESYESYESYESYESYESYESYESYESYESYES
8YESYESYESYESYESYESYESYESYESYESYES
Total25443233542
Abbreviations = 1: sequence generation; 2: assignment concealment; 3: personal blinding; 4: evaluator blinding; 5: incomplete tracking; 6: data reporting; 7: publication bias; 8: observer bias; the rating for each item includes the response to a question“, where “Yes” indicates a low risk “f ” bias, “No” indicates a high risk of bias, and “Unclear” indicates a lack of information or uncertainty about the potential for bias; the higher the score, the higher the risk of bias.
Table
Table 4. Results of the methodological quality assessment of included studies—PEDro Scale [11].
Table 4. Results of the methodological quality assessment of included studies—PEDro Scale [11].
ItemsArchiza
et al.,
2017 [16]		Edwards
et al.,
2008 [17]		Guy
et al.,
2014 [18]		Hart
et al.,
2001 [19]		Kilding et al.,
2016 [20]		Romer
et al.,
2001 [21]		Salazar-Martínez
et al.,
2017 [22]		Tong
et al.,
2008 [23]		Tong
et al.,
2010 [24]		Tranchita
et al.,
2018 [25]		Vascocelos
et al.,
2017 [26]
110000010001
211111111111
310000000001
411111111111
510101111000
600000000000
700000100000
81-111001001
91-010001100
1011111111111
1110001010010
Total83556556445
QualityGPRRGRRGRRR
Abbreviations = 1: eligibility criteria specified; 2: random allocation; 3: concealed allocation; 4: groups similar at baseline; 5: subject blinding; 6: therapist blinding; 7: sssessor blinding; 8: less than 15% dropouts; 9: intention-to-treat analysis; 10: between-group statistical comparisons; 11: paint measures and variability data; -: not evaluable; 1: YES; 2: NO; Quality score = total YES score; 9–11: eIllent (E); 6–8: good (G); 4–5: regular (R); <4: poor (P).
Table
Table 5. Cochrane’s assessment of quality [10].
Table 5. Cochrane’s assessment of quality [10].
ItemsArchiza
et al.,
2017 [16]		Edwards
et al.,
2008 [17]		Guy
et al.,
2014 [18]		Hart
et al.,
2001 19]		Kilding et al.,
2016 [20]		Romer
et al.,
2001 [21]		Salazar-Martínez
et al.,
2017 [22]		Tong
et al.,
2008 [23]		Tong
et al.,
2010 [24]		Tranchita
et al.,
2018 [25]		Vascocelos
et al.,
2017 [26]
1NONONONONONONONONONOYES
2YESNONONONONONONONONOYES
3YESYESYESYESYESYESYESYESYESYESYES
4YESNOYESNOYESYESYESYESNONONO
5NONONONONONONONONONONO
6NONONONONOYESNONONONONO
7YESYESYESYESYESYESYESYESYESYESYES
8YES-YESYESYES--YES--YES
9YES-YESYESNO--YES--YES
10YESYESYESYESYESYESYESYESYESYESYES
11YES-NOYESNO--YES--NO
Total83665547337
QualityGPGGRRRGPPG
Abbreviations = 1: Was the method of randomization adequate?; 2: Was the treatment allocation concealed?; 3: Were the groups similar at baseline?; 4: Was the patient blinded to the intervention?; 5: Was the care provider blinded to the intervention?; 6: Was the outcome assessor blinded to the intervention?; 7: Were co-interventions avoided or similar?; 8: Was the compliance acceptable in all groups?; 9: Was the drop-out rate described and acceptable?; 10: Was the timing of the outcome assessment similar in all groups similar?; 11: Did the analysis include an intention-to-treat analysis?; -: Not evaluable; 1: YES; 2: NO; Quality score = total YES score; 9–11 excellent (E); 6–8: good (G); 4–5: regular (R); <4: poor (P).
Table
Table 6. Characteristics of the sample and the intervention of selected articles and their quantitative analysis.
Table 6. Characteristics of the sample and the intervention of selected articles and their quantitative analysis.
Moderators’ VariableskMin.Max.MeanSD
Intervention variables
 Duration (weeks)11465.450.93
 Intensity (hours/week)0NANANANA
 Magnitude (hours/intervention)0NANANANA
Subjects’ variables
 Age (years)1019.053222.473.73
Methodology’s variables
 SS of the experimental group, at pretreatment11624125.6
 SS of the experimental group, at post-treatment1162111.635
 SS of the experimental group, at follow-up0----
 SS of the control group, at pretreatment116159.722.57
 SS of the control group, at post-treatment116159.452.42
 SS of the control group, at follow-up0----
 Mortality at post-treatment evaluation (%)11013.882.054.71
 Mortality at follow-up evaluation (%)0----
Abbreviations = SS: simple size; %: percentage; k: number of articles; Min.: minimum range; Max.: maximum range; SD: standard deviation; NA: data not available; -: not calculable.
Table
Table 7. Calculation of effect si’e by Rosenthal’s formula.
Table 7. Calculation of effect si’e by Rosenthal’s formula.
StudyOutcomes (Units)M (DT) preM (DT) Postp-ValueES
Archiza et al., 2017 [16]Respiratory pressures MIP (cmH2O)137 (15.3)166.5 (17.1)<0.051.51
Pulmonary function FVC (L)4.4 (1.0)4.2 (0.9)>0.050.27
Sports performance RSAmean (s)7.9 (0.2)7.6 (0.2)<0.051.19
Edwards et al., 2008 [17]Respiratory pressures MIP (cmH2O)148.1 (13.7)169.5 (9.1)<0.011.56
Pulmonary function FVC (L)5.5 (0.4)5.5 (0.6)>0.050.00
Sports performance-ET (s) 1000 m210 (52.2)205 (53.8)0.090.09
Guy et al., 2014 [18]Respiratory pressures MIP (cmH2O)134 (24.0)152 (21.0)0.0020.75
Pulmonary function FVC (L)5.25 (0.99)5.19 (0.9)>0.050.06
Sports performance MSFT (m)1491 (410)1666 (460)0.020.42
Hart et al., 2001 [19]Respiratory pressures MIP (cmH2O)127.8(ND)143.4 (NA)0.02-
Pulmonary function MVV (L/min)174 (ND)186 (NA) 0.65
Sports performance ET (s)848 (ND)887 (NA)0.22
Kilding et al., 2016 [20]Respiratory pressures MIP (cmH2O)115 (26.0)NA<0.010.41
Pulmonary function FVC (L)5.2 (0.7)0.60−0.07
Sports performance TT 200 m (strokes/min)43.7 (5.1)0.02−0.25
Romer et al., 2001 [21]Respiratory pressures MIP (cmH2O)130.3 (3.7)173.8 (6.0)<0.011.29
Pulmonary function FVC (L)5.63 (0.09)5.72 (0.09)>0.051.00
Sports performance RSP (s)243.9 (9.2)227.2 (9.0)<0.011.81
Salazar-Martínez et al., 2017 [22]Respiratory pressures MIP (cmH2O)119.6 (37.36)166.91 (42.65)<0.051.26
Pulmonary function FVC (L)5.44 (1.14)4.67 (1.38)>0.050.67
Sport performance WTTmean (W)217.25 (49.07)241.87 (56.01)0.020.50
Tong et al., 2008 [23]Respiratory pressures MIP (cmH2O)145.1 (19.6)191.3 (22.2)<0.051.35
Sports performance (number of repetitions)37.6 (5.9)43.7 (6.6)<0.051.03
Tong et al., 2010 [24]Respiratory pressures MIP (cmH2O)163 (29.8)195.9 (23.5)<0.011.10
Sports performance (number of repetitions)40.3 (5.0)52.7 (6.4)<0.050.89
Tranchita et al., 2018 [25]Respiratory pressures MIP (cmH2O)97.75 (23.85) 127.25 (22.12)<0.0010.95
Pulmonary function PIF (L/min)66.67(23.60) 87.58 (29.88)0.0050.77
Pulmonary function MVV (L/min)125.50(20.37)133.83 (25.0)0.0130.42
Sports performance Max Power (W)158 (34.48) 161 (34.50)>0.050.08
Vasconcelos et al., 2017 [26]Pulmonary function FVC (L)4.03 (0.45)4.34 (0.51)<0.050.68
Pulmonary function PEF (L/s)6.73 (1.51)7.17 (1.58)<0.050.52
Abbreviations = M (SD) pre: mean (standard deviation) at pretreatment; M (SD) post: mean (standard deviation) at post-treatment evaluation; ES: effect size; MIP: Maximum Inspiratory Pressure; FVC: Forced Vital Capacity; MVV: maximal voluntary ventilation; RSAmean: mean performance time; ET: exercise time; MSFT: multistage fitness test; TT: time trail; WTTmean: average watts; PIF: peak inspiratory flow; PEF: peak expiratory flow; NA: data not available. -: not calculable.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Fernández-Lázaro, D.; Corchete, L.A.; García, J.F.; Jerves Donoso, D.; Lantarón-Caeiro, E.; Cobreros Mielgo, R.; Mielgo-Ayuso, J.; Gallego-Gallego, D.; Seco-Calvo, J. Effects on Respiratory Pressures, Spirometry Biomarkers, and Sports Performance after Inspiratory Muscle Training in a Physically Active Population by Powerbreath®: A Systematic Review and Meta-Analysis. Biology 2023, 12, 56. https://doi.org/10.3390/biology12010056

AMA Style

Fernández-Lázaro D, Corchete LA, García JF, Jerves Donoso D, Lantarón-Caeiro E, Cobreros Mielgo R, Mielgo-Ayuso J, Gallego-Gallego D, Seco-Calvo J. Effects on Respiratory Pressures, Spirometry Biomarkers, and Sports Performance after Inspiratory Muscle Training in a Physically Active Population by Powerbreath®: A Systematic Review and Meta-Analysis. Biology. 2023; 12(1):56. https://doi.org/10.3390/biology12010056

Chicago/Turabian Style

Fernández-Lázaro, Diego, Luis A. Corchete, Juan F. García, David Jerves Donoso, Eva Lantarón-Caeiro, Raúl Cobreros Mielgo, Juan Mielgo-Ayuso, David Gallego-Gallego, and Jesús Seco-Calvo. 2023. "Effects on Respiratory Pressures, Spirometry Biomarkers, and Sports Performance after Inspiratory Muscle Training in a Physically Active Population by Powerbreath®: A Systematic Review and Meta-Analysis" Biology 12, no. 1: 56. https://doi.org/10.3390/biology12010056

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop